Diana M. M.
- Country
- Spain
- Department
- Oncology
Research Overview
- A Phase I Study of SIE-1 in Post-menopausal Women with Hormone Receptor-positive Early Breast Cancer
- Phase 3 Trial of Octreotide Subcutaneous Depot vs. Octreotide LAR or Lanreotide ATG in Unresectable/Metastatic GEP-NET Patients
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Trastuzumab Emtansine in High-Risk HER2-Positive Breast Cancer with Residual Disease
Data & Insights
Has run more than one trial at 142 of 344 partner sites.
Specializations
Breast Cancer and Other Solid Tumors
Clinical research activity centers on early-stage breast cancer, HER2-positive breast cancer, hormone receptor-positive breast cancer, and high-risk breast cancer, alongside broader work in non-small cell lung cancer, prostate cancer, hepatocellular carcinoma, colorectal cancer, and gastroenteropancreatic neuroendocrine tumors.
- Breast cancer recurrence and residual disease
- Non-small cell lung cancer and MET-targeted disease
- Prostate cancer and advanced solid tumors
- Colorectal cancer with peritoneal metastases
- Neuroendocrine tumors and liver cancer
Interest extends to tumor-directed strategies in both localized and advanced malignancies, with emphasis on disease control, relapse prevention, and treatment-resistant cancer settings.
Dermatology and Autoimmune Disease
The investigator is active in inflammatory skin and immune-mediated disorders, including moderate-to-severe plaque psoriasis, atopic dermatitis, vitiligo, chronic spontaneous urticaria, hidradenitis suppurativa, and cutaneous lupus erythematosus.
- Plaque psoriasis
- Atopic dermatitis
- Vitiligo
- Chronic spontaneous urticaria
- Cutaneous lupus erythematosus
Additional involvement includes immune-mediated skin disease with refractory or antimalarial-intolerant presentations, reflecting a strong therapeutic focus on chronic dermatologic inflammation.
Neurology and Psychiatry
Research interests include Parkinson’s disease, multiple sclerosis, Tourette syndrome, schizophrenia, generalized anxiety disorder, major depressive disorder, and attention-deficit/hyperactivity disorder.
- Parkinson’s disease and cognitive symptoms
- Multiple sclerosis
- Tourette syndrome
- Schizophrenia
- Anxiety and depressive disorders
The portfolio also covers movement disorders and neuropsychiatric conditions affecting symptom control, cognition, and functional burden.
Cardiometabolic, Renal, and Hematologic Conditions
Clinical trial involvement includes atherosclerotic cardiovascular disease, hypercholesterolemia, elevated lipoprotein(a), heart failure, obesity, chronic kidney disease, IgA nephropathy, primary immune thrombocytopenia, and multiple myeloma.
- Cardiovascular risk reduction
- Chronic kidney disease and renal protection
- Immune thrombocytopenia
- Multiple myeloma
- Metabolic disease and obesity-related care
This area also includes long-term management of lipid disorders and vascular prevention in patients with complex cardiometabolic profiles.
Infectious and Immune-Mediated Gastrointestinal Disease
Additional research activity spans chronic hepatitis B, HIV, mpox virus disease, respiratory syncytial virus infection, SARS-CoV-2 infection, Crohn’s disease, and ulcerative colitis.
- Chronic viral infection
- Mpox and emerging infection care
- Respiratory viral infection
- Crohn’s disease
- Ulcerative colitis
The therapeutic scope also includes chronic inflammatory bowel disease and infection-related conditions requiring ongoing clinical management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.